BAP1 as a guardian of genome stability: implications in human cancer

被引:21
|
作者
Kwon, Jongbum [1 ]
Lee, Daye [1 ]
Lee, Shin-Ai [1 ,2 ]
机构
[1] Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 03760, South Korea
[2] Natl Canc Inst, Ctr Canc Res, Lab Genitourinary Canc Pathogenesis, Bldg 37,Room 1068, Bethesda, MD 20892 USA
来源
EXPERIMENTAL AND MOLECULAR MEDICINE | 2023年 / 55卷 / 04期
基金
新加坡国家研究基金会;
关键词
NUCLEOTIDE EXCISION-REPAIR; PREVENTS CHROMOSOME INSTABILITY; DNA-DAMAGE RECOGNITION; TUMOR-SUPPRESSOR BAP1; HISTONE H2A; BRCA1-ASSOCIATED PROTEIN-1; MUTATIONS PREDISPOSE; DEUBIQUITINASE BAP1; UBIQUITIN HYDROLASE; REPLICATION STRESS;
D O I
10.1038/s12276-023-00979-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BAP1 is a ubiquitin C-terminal hydrolase domain-containing deubiquitinase with a wide array of biological activities. Studies in which advanced sequencing technologies were used have uncovered a link between BAP1 and human cancer. Somatic and germline mutations of the BAP1 gene have been identified in multiple human cancers, with a particularly high frequency in mesothelioma, uveal melanoma and clear cell renal cell carcinoma. BAP1 cancer syndrome highlights that all carriers of inherited BAP1-inactivating mutations develop at least one and often multiple cancers with high penetrance during their lifetime. These findings, together with substantial evidence indicating the involvement of BAP1 in many cancer-related biological activities, strongly suggest that BAP1 functions as a tumor suppressor. Nonetheless, the mechanisms that account for the tumor suppressor function of BAP1 have only begun to be elucidated. Recently, the roles of BAP1 in genome stability and apoptosis have drawn considerable attention, and they are compelling candidates for key mechanistic factors. In this review, we focus on genome stability and summarize the details of the cellular and molecular functions of BAP1 in DNA repair and replication, which are crucial for genome integrity, and discuss the implications for BAP1-associated cancer and relevant therapeutic strategies. We also highlight some unresolved issues and potential future research directions. Cancer: Investigating a genome-guarding protein A protein called BAP1, which removes tags marking proteins for degradation, is an important guardian of genome stability, and understanding its function may help in developing cancer therapies. People with mutations that inactivate BAP1 function always develop at least one and often multiple cancers, but specifically how BAP1 mutations cause cancer is not well understood. Jongbum Kwon and co-workers at Ewha Womans University in Seoul, South Korea, have reviewed how BAP1 functions, focusing on DNA repair. The authors report that BAP1 is crucial for repair of large DNA lesions, such as those caused by UV damage, and plays key roles in DNA replication, chromosome segregation, and disposal of cells with damaged DNA. These activities make BAP1 a powerful tumor suppressor, and improving our understanding of its mechanisms could point the way to new cancer treatments.
引用
收藏
页码:745 / 754
页数:10
相关论文
共 50 条
  • [31] Mesothelioma and BAP1 tumor predisposition syndrome: implications for public health
    Sassorossi, Carolina
    Chiappetta, Marco
    Congedo, Maria Teresa
    Flamini, Sara
    Campanella, Annalisa
    Evangelista, Jessica
    Iuliano, Rodolfo
    Boccuto, Luigi
    Lococo, Filippo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [32] Saturation genome editing of BAP1 functionally classifies somatic and germline variants
    Waters, Andrew J.
    Brendler-Spaeth, Timothy
    Smith, Danielle
    Offord, Victoria
    Tan, Hong Kee
    Zhao, Yajie
    Obolenski, Sofia
    Nielsen, Maartje
    van Doorn, Remco
    Murphy, Jo-Ellen
    Gupta, Prashant
    Rowlands, Charlie F.
    Hanson, Helen
    Delage, Erwan
    Thomas, Mark
    Radford, Elizabeth J.
    Gerety, Sebastian S.
    Turnbull, Clare
    Perry, John R. B.
    Hurles, Matthew E.
    Adams, David J.
    NATURE GENETICS, 2024, 56 (07) : 1434 - +
  • [33] Spectrum of BAP1 mutations identified in diverse cancer lineages
    Gatalica, Zoran
    Xiu, Joanne
    Swensen, Jeffrey
    Chen, Wangjuh
    CANCER RESEARCH, 2017, 77
  • [34] BAP1 Expression in Melanoma of the Skin
    Murali, R.
    Wilmott, J.
    Jakrot, V.
    Al-Ahmadie, H.
    Wiesner, T.
    McCarthy, S.
    Thompson, J.
    Scolyer, R.
    MODERN PATHOLOGY, 2013, 26 : 118A - 118A
  • [35] Tumours associated with BAP1 mutations
    Murali, Rajmohan
    Wiesner, Thomas
    Scolyer, Richard A.
    PATHOLOGY, 2013, 45 (02) : 116 - 126
  • [36] BAP1 Mutations in Rhabdoid Meningiomas
    Abedalthagafi, Malak
    MODERN PATHOLOGY, 2017, 30 : 428A - 428A
  • [37] BAP1 germline variants in Australia
    Hayward, N. K.
    Walpole, S.
    Palmer, J.
    Pritchard, A.
    Howlie, M.
    Symmons, J.
    Hamilton, H.
    Rolfe, O.
    Stark, A.
    D'Mellow, M.
    Warrier, S.
    Glasson, W.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 397 - 397
  • [38] BAP1 Mutations in Rhabdoid Meningiomas
    Abedalthagafi, Malak
    LABORATORY INVESTIGATION, 2017, 97 : 428A - 428A
  • [39] A spectrum of BAP1 expression from naevus to melanoma in a patient with BAP1 tumour predisposition syndrome
    Ogura, Yasuaki
    Shimauchi, Takatoshi
    Sugiyama, Tomoko
    Sugimura, Yuki
    Nakagawa, Masahiro
    Osawa, Harumo
    Kojima, Risa
    Iwaizumi, Moriya
    Honda, Tetsuya
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2025,
  • [40] BAP1 regulates HSF1 activity and cancer immunity in pancreatic cancer
    Yuan, Weiwei
    Zhang, Qiyue
    Zhao, Yuhan
    Xia, Wentao
    Yin, Shilin
    Liang, Xueyi
    Chen, Taoyu
    Li, Gaofeng
    Liu, Yanshen
    Liu, Zhiqiang
    Huang, Jinxi
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)